VITE20 Nail Gel: Label Checks and Client Referrals
For a client asking about VITE20, begin with the current product label and a clear plan for any nail health concern. Refer diagnosis and treatment questions to a qualified healthcare professional.
Can appearance alone confirm nail fungus?
The American Academy of Dermatology’s nail fungus guidance explains that nail psoriasis or an injury can look like nail fungus. A dermatologist may examine a nail sample to help confirm the diagnosis. A change in colour or texture needs appropriate assessment before selecting a treatment.
What to check before discussing VITE20
- Identify the exact product and obtain its current label from the supplier.
- Read the intended use, directions, ingredients and warnings on that label. Keep the instructions available for reference.
- Ask the supplier to clarify incomplete or conflicting product information before making a recommendation.
- Use only claims supported by the current label. Avoid promises about cure rates, speed of results or application through polish.
Can the client keep polish on during treatment?
The American Academy of Dermatology advises asking the treating dermatologist whether nail polish can be worn while treating nail fungus. Confirm the instructions for the specific treatment; a general product review cannot establish compatibility.
A practical salon response
“I can help you plan a cosmetic service within my training. Please ask a qualified healthcare professional to assess the nail concern and advise on treatment and polish before we choose the next service.”
Plan services within your training, salon policies and applicable local requirements. Keep current product instructions with your service resources and revisit the service plan once the client has appropriate advice.
Continue learning
- Salon Hygiene & Safety: browse professional service and workspace resources.
- Manicure & Pedicure: explore cosmetic service planning.
- Professional Resource Centre: find a reading path for your role.
Editorial correction: October 20, 2026. Revised to replace unsupported treatment and polish-compatibility claims with product-label checks and referral guidance.

